Noncovalent tagging of siRNA with steroids for transmembrane delivery

Biomaterials. 2018 Sep:178:720-727. doi: 10.1016/j.biomaterials.2018.02.007. Epub 2018 Feb 3.

Abstract

Short interfering RNA (siRNA) has broad applications in biology and medicine, and holds tremendous potential to become a new class of therapeutics for many diseases. As a highly anionic macrobiomolecule, its cytosolic delivery, however, has been a major roadblock in translation. Here, we report the development of small, bifunctional chemical tags capable of transporting siRNA directly into the cytosol. The bifunctional tags consist of a siRNA-binding moiety that interacts with siRNA non-covalently, and a steroid domain that readily fuses with the mammalian cell membrane. In contrast to the conventional covalently conjugated siRNA-steroid that enters cells largely via endocytosis which substantially limits siRNA bioavailability, the non-covalently tagged siRNA is cell membrane-permeant, avoiding the endocytic pathway. This new methodology enables effective RNA interference (RNAi) without the need of cationic transfection or endosomolytic agents, opening a new avenue for intracellular delivery of native biologics.

Keywords: Endocytosis; Intercalate; Non-covalent; Steroid; Transmembrane; siRNA delivery.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Death
  • Cell Line, Tumor
  • Cell Membrane / metabolism*
  • Cytosol / metabolism
  • Drug Delivery Systems*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Liver / metabolism
  • Male
  • Mice, Nude
  • RNA, Small Interfering / metabolism*
  • Steroids / administration & dosage*
  • Tissue Distribution

Substances

  • RNA, Small Interfering
  • Steroids